Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gianluca Svegliati Baroni
Brivanib in Combination With Notch3 Silencing Shows Potent Activity in Tumour Models
British Journal of Cancer
Cancer Research
Oncology
Related publications
Corrigendum to ‘Targeting FGFR2 With Alofanib (RPT835) Shows Potent Activity in Tumour Models’ [Eur J Cancer 61 (2016) 20–28]
European Journal of Cancer
Cancer Research
Oncology
TAS0728, a Covalent-Binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
Artesunate Shows Potent Anti-Tumor Activity in B-Cell Lymphoma
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Carboplatin and Oxaliplatin in Sequenced Combination With Bortezomib in Ovarian Tumour Models
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
Non-Canonical NOTCH3 Signalling Limits Tumour Angiogenesis
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
TAS4464, a Highly Potent and Selective Inhibitor of NEDD8 Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
A Dinucleotide Motif in Oligonucleotides Shows Potent Immunomodulatory Activity and Overrides Species-Specific Recognition Observed With CpG Motif
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination With Vorinostat in KRAS-Mutant Colorectal Cancer Models
Clinical Cancer Research
Cancer Research
Oncology
NIM811, a Cyclophilin Inhibitor, Exhibits Potent in Vitro Activity Against Hepatitis C Virus Alone or in Combination With Alpha Interferon
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
